GlucoGen Stocks Low

GlucoGen Stocks Low

European stocks of GlucoGen injections have been limited due to a manufacturing problem which has now been resolved but it will take a few months for Novo Nordisk to replenish their stocks.
Manufacturers Novo Nordisk say that the shortage is unlikely to affect people with diabetes directly as the company does have stock in its UK warehouse.

There are no quality or safety problems with the GlucGen products already in the supply chain.

However, as a precaution, Novo Nordisk is limiting supply to wholesalers to prevent reducing stocks too far. Stock will not be sold to wholesalers but kept in reserve to supply against patient prescriptions should the need arise. If pharmacists do require a direct order service because their wholesaler cannot supply, then they should contact Novo Nordisk directly on their customer Careline – 0845 600 5055.